Role of peritubular capillaries and vascular endothelial growth factor in chronic allograft nephropathy

L G Modelli de Andrade1, R M Viero, M F C Carvalho

  • 1Department of Internal Medicine, Botucatu Medical School, São Paulo State University, Botucatu, Brazil. gustavomodelli@yahoo.com.br

Transplantation Proceedings
|November 18, 2009
PubMed

Insights

Peritubular capillary damage and vascular endothelial growth factor (VEGF) are key in chronic allograft injury. Reduced peritubular capillaries and increased VEGF correlate with worse graft survival, highlighting their role in kidney transplant outcomes.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Pathology

Background:

  • Chronic allograft injury is a major cause of kidney transplant failure.
  • Peritubular capillaries and vascular endothelial growth factor (VEGF) are implicated in graft dysfunction.

Purpose of the Study:

  • To investigate the role of peritubular capillary damage and VEGF in chronic allograft injury.
  • To evaluate the correlation of these factors with clinical parameters and graft survival.

Main Methods:

  • Histologic analysis of CD34 (peritubular capillaries) and VEGF in 56 kidney transplant recipients with chronic graft dysfunction.
  • Classification into chronic allograft injury, cyclosporine toxicity, and control groups.

Main Results:

  • CD34 expression decreased with increasing Banff stage and correlated with age and rejection episodes.
  • VEGF increased in early chronic allograft injury and nephrotoxicity.
  • Low CD34 expression was linked to a higher risk of graft loss (OR 1.45).

Conclusions:

  • Peritubular capillaries diminish with chronic allograft injury progression.
  • VEGF shows a dynamic pattern, increasing early and decreasing late in nephropathy.
  • Loss of peritubular capillaries and VEGF overexpression are associated with poorer kidney allograft survival.
Abstract

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...